These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11309551)

  • 1. Furosemide-probenecid interaction as a laboratory exercise for undergraduate education in clinical pharmacology.
    Kawaguchi A; Sugimoto K; Ohmori M; Tsuruoka S; Harada K; Kitoh Y; Kobayashi E; Fujimura A
    Clin Pharmacol Ther; 2001 Apr; 69(4):232-7. PubMed ID: 11309551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable effect on postgraduate clinical practice of a drug-interaction exercise for undergraduate students.
    Tsuruoka S; Kawaguchi A; Harada K; Fujimura A
    Eur J Clin Pharmacol; 2006 Jul; 62(7):571-6. PubMed ID: 16724182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probenecid on furosemide response.
    Brater DC
    Clin Pharmacol Ther; 1978 Nov; 24(5):548-54. PubMed ID: 699479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M; Roberts C; Branch RA
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of torasemide, a new loop diuretic.
    Brater DC; Leinfelder J; Anderson SA
    Clin Pharmacol Ther; 1987 Aug; 42(2):187-92. PubMed ID: 3608350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evaluation of furosemide-probenecid interaction in humans.
    Smith DE; Gee WL; Brater DC; Lin ET; Benet LZ
    J Pharm Sci; 1980 May; 69(5):571-5. PubMed ID: 7381747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubular secretion and effects of furosemide.
    Odlind B; Beermann B
    Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic and non-diuretic actions of furosemide: effects of probenecid.
    Walshaw PE; McCauley FA; Wilson TW
    Clin Invest Med; 1992 Feb; 15(1):82-7. PubMed ID: 1572111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction studies with bumetanide and furosemide. Effects of probenecid and of indomethacin on response to bumetanide in man.
    Brater DC; Fox WR; Chennavasin P
    J Clin Pharmacol; 1981; 21(11):647-53. PubMed ID: 7338575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of bumetanide in the isolated perfused rat kidney: effects of probenecid and dose response.
    Bekersky I; Popick AC
    Am J Cardiol; 1986 Jan; 57(2):33A-37A. PubMed ID: 3946203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of co-administered organic acids on the kinetics and dynamics of frusemide.
    Sommers DK; Meyer EC; Moncrieff J
    Br J Clin Pharmacol; 1991 Oct; 32(4):489-93. PubMed ID: 1958444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin decreases furosemide-induced natriuresis and diuresis on the neonatal kidney.
    Reyes JL; Aldana I; Barbier O; Parrales AA; Melendez E
    Pediatr Nephrol; 2006 Nov; 21(11):1690-7. PubMed ID: 16932901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
    Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probenecid reduces cochlear effects and perilymph penetration of furosemide in chinchilla.
    Rybak LP; Green TP; Juhn SK; Morizono T
    J Pharmacol Exp Ther; 1984 Sep; 230(3):706-9. PubMed ID: 6470975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical investigations on the pharmacology of azosemide (SK-110) in comparison with furosemide in healthy volunteers.
    Kuzuya F; Sugino N; Yoshizumi K; Goto U; Oshima K
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):291-9. PubMed ID: 6746152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.
    Parrinello G; Paterna S; Di Pasquale P; Torres D; Mezzero M; Cardillo M; Fasullo S; La Rocca G; Licata G
    J Card Fail; 2011 Apr; 17(4):331-9. PubMed ID: 21440872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Furosemide and bumetanide: a study of responses in normal English and German subjects.
    Branch RA; Read PR; Levine D; Elst EV; Shelton J; Rupp W; Ramsay LE
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):538-45. PubMed ID: 1277709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.
    Verma AK; da Silva JH; Kuhl DR
    Ann Pharmacother; 2004 Apr; 38(4):544-9. PubMed ID: 14982985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.